Document:

Document

EXECUTION VERSION

Exhibit 4.5C

FIRST SUPPLEMENTAL INDENTURE
FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”) dated as of July 21, 2021, among GW Pharmaceuticals Limited, GW Global Services (International) Limited, GW Pharma Limited, GW Research Limited, GW UK Services Limited and Greenwich Biosciences, Inc. (each, a “New Guarantor” and collectively, the “New Guarantors”), JAZZ SECURITIES DESIGNATED ACTIVITY COMPANY (together with any successors thereto, the “Issuer”), and U.S. Bank National Association, as trustee under the Indenture referred to below (the “Trustee”).
W I T N E S S E T H :
WHEREAS the Issuer and the Trustee have heretofore executed an indenture, dated as of April 29, 2021 (as amended, supplemented or otherwise modified, the “Indenture”), providing for the issuance of the Issuer’s 4.375% Senior Secured Notes due 2029 (the “Notes”), initially in the aggregate principal amount of $1,500,000,000;
WHEREAS Sections 4.11 and 12.07 of the Indenture provide that under certain circumstances the Issuer is required to cause the New Guarantors to execute and deliver to the Trustee a supplemental indenture pursuant to which the New Guarantors shall guarantee the Guaranteed Obligations; and
WHEREAS pursuant to Section 9.01 of the Indenture, the Trustee, the New Guarantors and the Issuer are authorized to execute and deliver this Supplemental Indenture;
NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the New Guarantors, the Issuer and the Trustee mutually covenant and agree for the equal and ratable benefit of the holders of the Notes as follows:
1.    Defined Terms.  Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.  The words “herein,” “hereof” and “hereby” and other words of similar import used in this Supplemental Indenture refer to this Supplemental Indenture as a whole and not to any particular Section hereof.
2.    Agreement to Guarantee.  Each New Guarantor hereby agrees, jointly and severally with all existing Guarantors (if any), to guarantee the Guaranteed Obligations on the terms and subject to the conditions set forth in Article XII of the Indenture and to be bound by all other applicable provisions of the Indenture and the Notes and to perform all of the obligations and agreements of a Guarantor under the Indenture.
3.    Notices.  All notices or other communications to the New Guarantors shall be given as provided in Section 13.02 of the Indenture.
4.    Ratification of Indenture; Supplemental Indentures Part of Indenture.  Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect.  This Supplemental Indenture shall form a part of the Indenture for all purposes, and every holder of Notes heretofore or hereafter authenticated and delivered shall be bound hereby.
5.    Governing Law.  THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.
6.    Trustee Makes No Representation.  The Trustee accepts the amendments of the Indenture effected by this Supplemental Indenture on the terms and conditions set forth in the Indenture, including the terms and provisions defining and limiting the liabilities and responsibilities of the Trustee.  Without limiting the generality of the foregoing, the Trustee shall not be responsible in any manner whatsoever for or with respect to any of the recitals or statements contained herein, all of which recitals or statements are made solely by the Issuer, or for or with respect to (i) the validity or sufficiency of this Supplemental Indenture or any of the terms or provisions hereof, (ii) 

the proper authorization hereof by the Issuer and each New Guarantor, in each case, by action or otherwise, (iii) the due execution hereof by the Issuer and each New Guarantor or (iv) the consequences of any amendment herein provided for, and the Trustee makes no representation with respect to any such matters.
7.    Counterparts.  The parties may sign any number of copies of this Supplemental Indenture.  Each signed copy shall be an original, but all of them together represent the same agreement.  One signed copy is enough to prove this Supplemental Indenture.  Notwithstanding the foregoing, the exchange of copies of this Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture and signature pages for all purposes.
8.    Effect of Headings.  The Section headings of this Supplemental Indenture have been inserted for convenience of reference only, are not intended to be considered a part hereof and shall not modify or restrict any of the terms or provisions here.
[Remainder of page intentionally left blank.]

IN WITNESS WHEREOF, the parties have caused this Supplemental Indenture to be duly executed as of the date first written above.

JAZZ SECURITIES DESIGNATED ACTIVITY COMPANY, as Issuer
By:       /s/ Patricia Carr    
    Name: Patricia Carr
    Title:  Director
GW PHARMACEUTICALS LIMITED, as a New Guarantor
By:       /s/ Iain Ward    
    Name: Iain Ward
    Title:  Director
GW GLOBAL SERVICES (INTERNATIONAL) LIMITED, as a New Guarantor
By:       /s/ Iain Ward    
    Name: Iain Ward
    Title:  Director
GW PHARMA LIMITED, as a New Guarantor 
By:       /s/ Iain Ward    
    Name: Iain Ward
    Title:  Director
GW RESEARCH LIMITED, as a New Guarantor 
By:       /s/ Iain Ward    
    Name: Iain Ward
    Title:  Director

[Signature Page to First Supplemental Indenture]

GW UK SERVICES LIMITED, as a New Guarantor 

By:       /s/ Iain Ward    
    Name: Iain Ward
    Title:  Director

GREENWICH BIOSCIENCES, INC., as a New Guarantor 

By:       /s/ Joshua Eizen    
    Name: Joshua Eizen
    Title: Secretary

[Signature Page to First Supplemental Indenture]

U.S. BANK NATIONAL ASSOCIATION, not in its individual capacity, but solely as Trustee
By:         /s/ Christopher J. Grell    
    Name:    Christopher J. Grell
    Title:       Vice President
[Signature Page to First Supplemental Indenture]Document

                

Exhibit 10.1A
AMENDMENT #1

TO PHARMACY SERVICES MASTER SERVICES AGREEMENT
This Amendment #1 to Pharmacy Master Services Agreement (“Amendment”), effective as of the last date signed below (the “Effective Date”), is made pursuant to the terms of the Pharmacy Services Master Services Agreement (“Agreement”), effective as of July 1, 2020 between Jazz Pharmaceuticals, Inc. (“Jazz Pharmaceuticals”) and Express Scripts Specialty Distribution Services, Inc. (“ESSDS”) (individually, “Party” and collectively, “Parties”), the terms of which are incorporated herein by reference.
Whereas, ESSDS intends to relocate the fulfillment operations of the Certified Pharmacy.

Now therefore, in consideration of the above recital, which is incorporated by this reference, the mutual promises and covenants set forth below, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

1.Section 4.9 Certified Pharmacy Relocation is hereby added to the Agreement:
4.9 Certified Pharmacy Relocation
a.Jazz Pharmaceuticals acknowledges that ESSDS intends to relocate the
fulfillment operations of the Certified Pharmacy from its’ current address of 8931 Springdale Ave. Ste. A St. Louis, MO 63134 to 4600 North Hanley Rd. Ste. B St. Louis, MO 63121 at the close of business on July 16, 2021.
b.ESSDS shall be solely responsible for all out-of-pocket costs incurred as a result of this relocation.
c.At all times during this relocation, ESSDS shall handle, maintain, store, transport and deliver the Product in accordance with all Applicable Laws and SOPs.
d.ESSDS will not dispense from more than one Certified Pharmacy location at a time and will continue to provide Services in accordance with Section 2.8 of the Pharmacy Master Services Agreement.
2.Exhibit B hereby deleted and replaced in its’ entirety with Exhibit B below.
3.In the event of any conflict or inconsistency between the terms and provisions of the Agreement and the terms and provisions of this Amendment, the terms and provisions of this Amendment will govern and prevail. Except as expressly provided in this Amendment, this Amendment does not in any way change, modify or delete the provisions of the Agreement (or the Parties’ rights, remedies or obligations thereunder), 
1

                

and all such provisions shall remain in full force and effect. On and after the Amendment Effective Date, each reference in the Agreement to “this Agreement,” “hereunder,” “hereof,” “herein,” or words of like import, and each reference to the Agreement in any other agreements, documents or instruments executed and delivered pursuant to the Agreement, shall mean and be a reference to the Agreement, as amended by this Amendment.

IN WITNESS WHEREOF, by signature of their respective duly authorized representatives below, the Parties have agreed to this Amendment as of the Effective Date.

						
	EXPRESS SCRIPTS SPECIALTY  DISTRIBUTIONS SERVICES, INC.
	JAZZ PHARMACEUTICALS, INC.

	

  By: Joshua B. Parker
	

By: Debra Feldman

	  Signature:  /s/ Joshua B. Parker
	Signature:  /s/ Debra Feldman

	  Title:  VP
	Title: VP, Pharmacovigilance

	   Date: 07/01/2021 |  9:25 AM CDT
	Date:04-Jul-2021

           RPM for JLD  7.1.21
2

                

Exhibit B

ESSDS LOCATIONS

Express Scripts Building 3 4600 North Hanley Rd. Suite B St. Louis, MO 63121

Express Scripts Building 6 4700 North Hanley Rd. St. Louis, MO 63134
3Document

Exhibit 10.1B

AMENDMENT #2

TO PHARMACY SERVICES MASTER SERVICES AGREEMENT
This Amendment #2 to Pharmacy Master Services Agreement (“Amendment”), effective as of the last date signed below (the “Effective Date”), is made pursuant to the terms of the Pharmacy Services Master Services Agreement (“Agreement”), effective as of July 1, 2020 between Jazz Pharmaceuticals, Inc. (“Jazz Pharmaceuticals”) and Express Scripts Specialty Distribution Services, Inc. (“ESSDS”) (individually, “Party” and collectively, “Parties”), the terms of which are incorporated herein by reference.
Whereas, ESSDS intends to relocate the fulfillment operations of the Certified Pharmacy.

Now therefore, in consideration of the above recital, which is incorporated by this reference, the mutual promises and covenants set forth below, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

1.    Exhibit B hereby deleted and replaced in its’ entirety with Exhibit B below.
2.    In the event of any conflict or inconsistency between the terms and provisions of the Agreement and the terms and provisions of this Amendment, the terms and provisions of this Amendment will govern and prevail. Except as expressly provided in this Amendment, this Amendment does not in any way change, modify or delete the provisions of the Agreement (or the Parties’ rights, remedies or obligations thereunder), and all such provisions shall remain in full force and effect. On and after the Amendment Effective Date, each reference in the Agreement to “this Agreement,” “hereunder,” “hereof,” “herein,” or words of like import, and each reference to the Agreement in any other agreements, documents or instruments executed and delivered pursuant to the Agreement, shall mean and be a reference to the Agreement, as amended by this Amendment.

1

IN WITNESS WHEREOF, by signature of their respective duly authorized representatives below, the Parties have agreed to this Amendment as of the Effective Date.

									
	EXPRESS SCRIPTS SPECIALTY DISTRIBUTIONS SERVICES, INC. 		JAZZ PHARMACEUTICALS, INC.
	By:  Joshua B Parker                       
		By:  /s/ Debra Feldman                   

	Signature:  /s/ Joshua B. Parker      
		Signature:   Debra Feldman            

	Title:           VP                                 
		Title:   VP, Pharmacovigilance        

	Date:     7/13/2021 |  3:52 PM CDT  
		Date:   19-Jul-2021                          

			
	              RPM for JLD  7.13.21		
			
			

2

Exhibit B

ESSDS LOCATIONS

Express Scripts Building 3 4600 North Hanley Rd. Suite B St. Louis, MO 63134

Express Scripts Building 6 4700 North Hanley Rd. St. Louis, MO 63134
3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}]]